Physician profile
Patrick B White
NPI 1891952271
$2,779.37
in general payments reported to CMS, 2019-2025
27 companies · $808 in 2025
The $808 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $86.38 · 2021: $16.60 · 2022: $386 · 2023: $413 · 2024: $703 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,923.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,451.42 | 2019-2025 | Rinvoq, Skyrizi |
| Tela Bio, INC. | $186.87 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Janssen Biotech, INC. | $144.82 | 2024-2025 | Stelara, Tremfya, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $106.61 | 2020-2025 | Gattex, Entyvio |
| Axonics, INC. | $101.12 | 2022-2024 | Axonics |
| Innovation Technologies INC | $90.91 | 2022 | |
| Braintree Laboratories, INC. | $77.67 | 2019-2025 | Sutab, Suflave |
| Medtronic, INC. | $74.49 | 2022-2025 | Interstim |
| Lumendi LLC | $69.25 | 2019 | |
| Smith+Nephew, INC. | $53.61 | 2024-2025 | Grafix Pl, Stravix Pl |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.07 | 2019 | |
| Davol INC. | $48.88 | 2024-2025 | Arista Ah Flexitip, Arista |
| Kerecis Limited | $47.95 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Baxter Healthcare | $44.70 | 2022 | |
| Hologic Sales and Service, LLC | $27.93 | 2025 | Coolseal Generator |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $26.92 | 2025 | Novosorb Btm |
| Micro-Tech Endoscopy USA, INC. | $24.03 | 2024 | Inflation Device |
| Shire North American Group INC | $23.59 | 2019 | |
| Celgene Corporation | $18.40 | 2024 | Zeposia |
| Hospira, INC. | $18.10 | 2019 | |
| Hologic INC | $16.60 | 2021 | |
| Pfizer INC. | $13.73 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.70 | 2019 | |
| Medtronic USA, INC. | $12.91 | 2019 | |
| Integra Lifesciences Corporation | $12.74 | 2020 | |
| Amgen INC. | $10.94 | 2019 | |
| Biocomposites INC | $8.41 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.